Cancer Diagnostics

In an age of precision medicine, rapidly advancing biomarkers, and innovative cancer screening technologies, the demand for up-to-date information and tools is increasing like never before. The ACCC has been on the forefront of this demand for years, highlighting the expanding role of biomarkers in cancer diagnosis, prognosis, and treatment selection, as well as providing insights and tools to support multidisciplinary cancer care team members.

Through various educational initiatives, the ACCC deconstructs these complex advancements to deliver the clear and targeted information that multidisciplinary cancer care team members need to know. With access to these curated resources, team members can be confident in their ability to discuss the role of diagnostics and biomarker testing with their patients and caregivers, particularly those from underserved populations.

Key learning objectives for this area of focus include:

• Creating and curating precision medicine resources designed to aid cancer care team members when discussing the role of diagnostics/biomarker testing with patients and caregivers, particularly those from underserved populations
• Disseminating data on innovative cancer screening technologies, biomarker testing updates, and related targeted treatments
• Reinforcing the importance of multidisciplinary teams and greater integration of patients, caregivers, and members of at-risk communities when creating cancer diagnostic messaging and resources
• Developing clinically relevant, disease-specific educational updates related to cancer diagnostics and precision medicine
• Convening multidisciplinary leaders from the oncology community to translate and provide cancer precision medicine commentary applicable to the broad ACCC membership

Featured Resources

Saint Luke’s Precision Medicine Program Spotlight

Discover how more than 400 patients with cancer have received life-changing, targeted treatment recommendations from the multidisciplinary team at Saint Luke’s Center for Precision Oncology—where care is tailored to the tumor, not just the diagnosis.¹ To showcase their innovative work, ACCC presents a 5-part video series featuring insights from program champions and powerful stories from patient advocates.

• Care Coordination
• Biomarker Testing
• Clinical Trials
• Shared Decision-Making
• Tips From Saint Luke’s Cancer Institute

Source: 1. https://www.saintlukeskc.org/center-precision-oncology

Tip Sheets

As the precision medicine testing landscape becomes increasingly complex, ACCC has curated actionable tip sheets to help cancer care teams navigate biomarker testing for gynecologic tumors, newly identified mutations, hereditary cancer syndromes as well as optimize the use of liquid biopsy and communicate biomarker test results effectively. Download these helpful guides today.

• Optimizing the Role of Liquid Biopsy
• Newly Identified Actionable Mutations
• A Guide to Biomarkers in Gynecologic Tumors
• Germline vs Somatic Testing for Cancer
• Communicating Biomarker Test Results

Featured Publication

Expanding Access to Biomarker Testing

Consistent, affordable, and equitable access to biomarker testing remains elusive. Uneven coverage of guideline-concordant testing compounds anxiety and distress for patients insured by Medicaid. View a breakdown of states with pending or enacted legislation to expand biomarker testing access and find information on resources to aid its implementation, including a lexicon of relevant terminology for multidisciplinary care teams and a resource library with materials to support patients and providers alike.
Download the Publication

For more information on this project, please contact the ACCC Provider Education department.